Another study indicated that the estimated lifetime breast cancer risk for BRCA1 and BRCA2 PV carriers increased with higher PRS313 scores, though the observed effect was smaller than in the general population or among carriers of PVs in ATM, CHEK2, and PALB2 [63]. Here, CHEK2 is linked to breast cancer.